Cooperative Agreement NU58DP006256

The Maternal and Child Health Federal Consolidated Programs (CFDA 93.110) awarded a $2,248,780 project grant to Boston Medical Center (BMC) and the Epilepsy Foundation New England (EFNE) to develop, implement, evaluate, and scale up five innovative strategies to improve outcomes for youth with epilepsy (YWE) and youth with epilepsy and developmental disabilities (YEDD) during their transition from child- to adult-serving systems. The project will support 9,066 YWE and their families across...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) provides $599,914.00 to New York University School of Medicine to conduct an economic evaluation of self-management programs for individuals with epilepsy. The project aims to assess the costs and benefits of the Mastering Epilepsy with Wellness (MEW) Network, which delivers self-management interventions to help people with epilepsy...

The University of Arizona was awarded a $600,000 Cooperative Agreement under the Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283) to conduct an economic analysis of an evidence-based epilepsy self-management intervention called MINDSET in community and healthcare settings. The award, with a performance period from September 30, 2024 to September 29, 2027, will support research to evaluate the costs and benefits of implementing this new...

This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $191,382 to the University of Virginia (UVA) to develop a risk stratification algorithm to identify individuals with Alzheimer's disease and related dementias (ADRD) who are at high risk of developing epilepsy. The research aims to 1) develop and test this risk prediction model, and 2) determine the feasibility of using electroencephalogram (EEG) to detect differences in epileptiform activity...

The U.S. Department of Health and Human Services' Maternal and Child Health Federal Consolidated Programs (CFDA 93.110) awarded a $900,000 Project Grant to the University of Minnesota's Institute on Community Integration to establish the "Transition for Youth with Autism and/or Epilepsy Demonstration Projects" in Minnesota. This 5-year project (Sep 2024 - Aug 2029) aims to improve coordination and communication among education, healthcare, and vocational rehabilitation services for...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $657,958 to Boston University to conduct research on the cellular and network mechanisms underlying epilepsy and neuromodulation. The research aims to elucidate the neuronal mechanisms of epileptic activity, the relationship between spike ripples and seizures, and the...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is providing $690,763 to Brigham & Women's Hospital Inc. to optimize neuromodulation therapies for epilepsy. The key objectives are to: 1) identify patient-specific brain connectivity networks and stimulation fields crucial for positive outcomes with responsive neurostimulation (RNS)...

The U.S. Department of Health and Human Services, through the Maternal and Child Health Federal Consolidated Programs (CFDA 93.110), awarded a $450,000 Project Grant to the Michigan Department of Health and Human Services. The grant, awarded on September 1, 2024, will fund a 5-year project to improve the quality of life and well-being of Michigan youth with epilepsy (YES), ages 13-26, transitioning from pediatric to adult healthcare. The project aims to build a structured healthcare transition...

The Defense Health Agency awarded Oklahoma State University a $371,617 Block Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research related to epilepsy. The award will support a 3-year project focused on two key objectives: Improving prediction of post-traumatic epilepsy (PTE) by enhancing machine learning models using electronic health record data from the VA and other sources. This will involve data preprocessing, model training, and the use of...

This federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), aims to characterize the genetic and transcriptomic architecture of epilepsy in baboons. The $582,656 award, with a project period from September 18, 2024 to August 31, 2025, will enable the University of Texas at San Antonio to: Identify epilepsy-risk genetic variants and...